Newslist

We congratulate Johannes Kullmann, who won the Best Poster Prize at Microbes and RNA 2023, an award sponsored by the journal 'microLife'.

Congratulations! At this year's annual conference of the DGHM in Lübeck, Cynthia Sharma was awarded the DGHM Main Prize. The main prize is awarded to scientists with outstanding and usually long-standing research activity in a current and promising field of hygiene and microbiology.

In 1993, the Research Center for Infectious Diseases (ZINF) and the Institute of Molecular Infection Biology (IMIB) were founded. On July 20, both now celebrated their 30th anniversaries.

From 27 June to 1 July, the internationally renowned and annual CRISPR Conference was held at the University of Würzburg, jointly organised by HIRI (Helmholtz Institute for RNA-based Infection Research) and IMIB (Institute of Molecular Infection Research).

At this year's city cycling, the cyclists from IMIB, HIRI and RVZ, who were registered as "Team D15" for the competition 2023, were convincing.

Emmanuel Saliba, an expert in single-cell RNA sequencing, has accepted a W2 professorship at the School of Medicine and will start at the Institute of Molecular Infection Biology on May 1.

Jörg Vogel, Director of the Institute of Molecular Infection Biology (IMIB) and of the Helmholtz Institute for RNA-based Infection Research (HIRI) has been elected a full member of the Bavarian Academy of Sciences and Humanities. Becoming a member of the Bavarian Academy of Sciences and Humanities is one of the most prestigious scientific honors in Bavaria.

It investigates critical decision processes that determine the outcome of human infection. The German Research Foundation announced the establishment of the new SFB on November 25, 2022; it will fund it with 10.7 million euros over the next four years.

On October 6, Cynthia Sharma and Chase Beisel were awarded the Pettenkofer Prize 2022 for their pioneering work in the field of "innovative methods for the diagnosis of viral infections" in Munich.

The federal government (BMBF) is providing 2.4 million euros for a new research group in infectious disease research at the IMIB/ZINF of the JMU Würzburg.

Some bacteria do not grow or grow very slowly, often rendering antibiotics ineffective. An international team, including the University of Würzburg, aims to find a new way to combat these bacteria.